|
Week - 1
|
Bioavailability, definitions and historical perspective |
|
Week - 2
|
Fundamentals of bioavailability |
|
Week - 3
|
Definition and history of bioequivalence |
|
Week - 4
|
Fundamentals of drug absorption, bioavailability and bioequivalence |
|
Week - 5
|
Pharmaceutical factors affecting bioavailability and bioequivalence |
|
Week - 6
|
Bioavailability in controlled-release dosage forms |
|
Week - 7
|
The importance of dissolution rate in bioavailability |
|
Week - 8
|
Effect of physiological factors on bioavailability and bioequivalence |
|
Week - 9
|
Study design and statistical approaches in determining bioavailability and bioequivalence |
|
Week - 10
|
Drugs with bioavailability problems |
|
Week - 11
|
Analytical methods used in bioavailability and bioequivalence and their validation |
|
Week - 12
|
Harmonization in bioavailability and bioequivalence studies |
|
Week - 13
|
In-vitro bioavailability |
|
Week - 14
|
Discussion and evaluation |